Case report demonstrates effective heparin-free VV-ECMO support for critical airway procedures in patients with advanced laryngeal tumors, indicating a promising intervention.
Background: Critical upper airway obstruction caused by advanced laryngeal malignancy poses an extreme risk of airway loss during induction of anesthesia and instrumental airway management. Veno-venous extracorporeal membrane oxygenation (VV-ECMO) has emerged as a strategy to enable safe performance of high-risk airway interventions. However, reports on heparin-free protocols in this setting remain scarce. Methods: A 46-year-old male with progressive dyspnea caused by a large laryngeal tumor reducing the residual glottic lumen to ~1 mm was admitted urgently. Safe endotracheal intubation was deemed impossible. Elective heparin-free VV-ECMO was established under local anesthesia via percutaneous femoro-femoral cannulation before induction of general anesthesia. Results: Under ECMO support, a technically demanding tracheostomy and tumor biopsy were performed without hypoxemic episodes. VV-ECMO was maintained postoperatively for 48 h without systemic anticoagulation and was weaned without hemorrhagic or thrombotic complications. Histopathology confirmed squamous cell carcinoma grade 2; the patient was discharged home after initiation of systemic immunotherapy. Conclusions: Elective heparin-free VV-ECMO can provide effective and safe respiratory support for patients with critical airway obstruction undergoing high-risk airway procedures. Pre-emptive cannulation under local anesthesia, femoro-femoral access in anatomically compromised necks, and short heparin-free circuit runs mitigate both airway and hemorrhagic risk. Prospective studies are needed to establish standardized patient selection criteria and anticoagulation protocols.
No takes yet. Share an insight, caveat, or question.
Prokop et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: